Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07175454 Sponsor: The Royal Wolverhampton Hospitals NHS Trust Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07175454
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with ulcerative colitis or Crohn's disease, confirmed by a specialist team, clinic records, or the opinion of the investigating doctor.
  • People who are currently receiving regular infliximab or vedolizumab treatment given through a drip (intravenous infusion).
  • People who are willing and able to give their informed consent to take part.
  • People aged 16 or over.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are still in the early "loading dose" phase of their infusion treatment (though joining may be possible once that phase is finished).
  • People for whom surgery is already planned within the next 12 months.
  • People for whom a switch to a different advanced therapy is already planned within the next 12 months.
  • People for whom a planned break from their medication (drug holiday) is scheduled within the next 12 months.
  • People who have a stoma (a surgically created opening on the abdomen for waste removal).
  • People who are currently pregnant.
  • People who are currently receiving infliximab or vedolizumab as an injection under the skin (subcutaneous), rather than through a drip.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The Royal Wolverhampton Hospitals NHS Trust
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Patient Reported Outcome-2 (PRO-2); Patient Health Questionnaire-9 (PHQ-9); Generalised Anxiety Disorder-7 (GAD-7); Perceived Stress Scale (PSS-10)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov